Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Comparison of dominant fund strategies for retirement, weighing SP 500 versus Total Market to guide your decision.
28,607 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Regulators in the UK are moving to dissolve a crypto exchange accused of aiding sanctions evasion. This article break...
Airbnb hosting has evolved from a side gig to a steady income for many homeowners. But as airbnb services have pushed...
Long security lines at major airports are forcing travelers to rethink flights and budgets. This story breaks down re...
As Oregon voters head into a pivotal primary, a gas-tax hike and related fees put affordability at the forefront. Thi...
A new NBER study ties political promises about loan forgiveness to bigger defaults and altered spending, underscoring...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
After closing on a rental property, one diligence item can determine whether your cash flow meets expectations. This ...
A leading AI stock is rumored to have secured a deal worth over $100 billion. This article breaks down what that coul...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
As Joby Aviation gears up for commercial flights in 2026, investors are weighing a bold ramp in production, regulator...
Broadcom and Microsoft posted AI-driven quarters, underscoring two distinct strategies: Broadcom sells AI chips to hy...